NCT00346567View on ClinicalTrials.gov

Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)

NACompletedINTERVENTIONAL
Enrollment

566

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

April 30, 2011

Conditions
HIV Infections
Interventions
DRUG

Zidovudine and Lamivudine (Combivir)

DRUG

Emtricitabine and Tenofovir (Truvada)

Trial Locations (1)

Unknown

Bombo Regional Hospital, Tanga

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT00346567 - Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT) | Biotech Hunter | Biotech Hunter